Abstract
Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinoline alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover, astrocytes are proving critical for normal CNS function, and alterations in their activity and impaired oxidative stress could contribute to diabetes-related cognitive dysfunction. Metabolic and oxidative insults often cause rapid changes in glial cells. Key indicators of this response are increased synthesis of glial fibrillary acidic protein (GFAP) as an astrocytic marker. Therefore, we examined the effects of berberine on glial reactivity of hippocampus in streptozotocin (STZ)-induced diabetic rats, using GFAP immunohistochemistry. Lipid peroxidation, superoxide dismutase (SOD) activity, and nitrite levels were assessed as the parameters of oxidative stress. Eight weeks after diabetes induction, we observed increased numbers of GFAP+ astrocytes immunostaining associated with increased lipid peroxidation, decreased superoxide dismutase activity, and elevated nitrite levels in the hippocampus of STZ-diabetic rats. In contrast, chronic treatment with berberine (50 and 100 mg/kg p.o. once daily) lowered hyperglycemia, reduced oxidative stress, and prevented the upregulation of GFAP in the brain of diabetic rats. In conclusion, the present study demonstrated that the treatment with berberine resulted in an obvious reduction of oxidative stress and GFAP-immunoreactive astrocytes in the hippocampus of STZ-induced diabetic rats.
Similar content being viewed by others
References
Northam EA et al (2009) Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32:445–450. doi:10.2337/Dc08-1657
Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567–575. doi:10.1016/j.freeradbiomed.2010.12.006
Russell JW et al (2008) Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 30:420–429. doi:10.1016/j.nbd.2008.02.013
Pitocco D et al (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud: RDS 7:15–25. doi:10.1900/RDS.2010.7.15
Pekny M, Pekna M (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204:428–437. doi:10.1002/path.1645
Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167–178. doi:10.1016/j.taap.2006.01.003
Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7:494–506. doi:10.1016/j.nurt.2010.07.003
Kimelberg HK, Nedergaard M (2010) Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338–353. doi:10.1016/j.nurt.2010.07.006
Baydas G et al (2003) Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 35:797–804. doi:10.1016/S0891-5849(03)00408-8
Pekny M, Wilhelmsson U, Bogestål YR, Pekna M (2007) In: Tiziana Corasaniti Giacinto Bagetta M, Lipton Stuart A (eds) International review of neurobiology, vol. 82. Academic, New York, pp 95–111
Middeldorp J, Hol EM (2011) GFAP in health and disease. Prog Neurobiol 93:421–443. doi:10.1016/j.pneurobio.2011.01.005
Coleman E, Judd R, Hoe L, Dennis J, Posner P (2004) Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166–178. doi:10.1002/glia.20068
Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22:999–1012. doi:10.1002/ptr.2399
Kulkarni SK, Dhir A (2008) On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 589:163–172. doi:10.1016/j.ejphar.2008.05.043
Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24:317–324. doi:10.1002/Ptr.2968
Bhutada P et al (2011) Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 220:30–41. doi:10.1016/j.bbr.2011.01.022
Cok A et al (2011) Berberine acutely activates the glucose transport activity of GLUT1. Biochimie 93:1187–1192. doi:10.1016/j.biochi.2011.04.013
Gu Y et al (2010) Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81:766–772. doi:10.1016/j.talanta.2010.01.015
Lee YS et al (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256–2264. doi:10.2337/Db06-0006
Zhou JY et al (2009) Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 606:262–268. doi:10.1016/j.ejphar.2008.12.056
Kong WJ et al (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109–119. doi:10.1016/j.metabol.2008.08.013
Huang L, Shi AD, He F, Li XS (2010) Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorgan Med Chem 18:1244–1251. doi:10.1016/j.bmc.2009.12.035
Peng WH, Hsieh MT, Wu CR (1997) Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Jpn J Pharmacol 74:261–266
Zhu, F. Q., Qian, C. Y. (2006) Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 7, doi:10.1186/1471-2202-7-78
Yoo JH et al (2006) Inhibitory effects of berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice. Neuroscience 142:953–961. doi:10.1016/j.neuroscience.2006.07.008
Moghaddam HK, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. Metab Brain Dis. doi:10.1007/s11011-013-9411-5
Choi S-W, Benzie IFF, Ma S-W, Strain JJ, Hannigan BM (2008) Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 44:1217–1231. doi:10.1016/j.freeradbiomed.2007.12.005
Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1–34. doi:10.1016/j.pharmthera.2008.05.005
Orie NN, Zidek W, Tepel M (1999) Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 12:1169–1174. doi:10.1016/S0895-7061(99)00129-6
Hirao K et al (2010) Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes. Obes Res Clin Pract 4:e83–e90. doi:10.1016/j.orcp.2009.09.004
Steel JH et al (1994) Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 169:81–84. doi:10.1016/0304-3940(94)90361-1
Sepici-Dincel A, Açıkgöz Ş, Çevik C, Sengelen M, Yeşilada E (2007) Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol 110:498–503. doi:10.1016/j.jep.2006.10.015
Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67–71. doi:10.1016/S0014-2999(03)01294-9
Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res: PTR 24:317–324. doi:10.1002/ptr.2968
Wang X et al (2005) Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 77:3058–3067. doi:10.1016/j.lfs.2005.02.033
Zhou J-Y, Zhou S-W (2011) Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 82:184–189. doi:10.1016/j.fitote.2010.08.019
Yin J, Ye J, Jia W (2012) Effects and mechanisms of berberine in diabetes treatment. Acta Pharm Sin B 2:327–334. doi:10.1016/j.apsb.2012.06.003
Siow YL, Sarna L, Karmin O (2011) Redox regulation in health and disease—therapeutic potential of berberine. Food Res Int 44:2409–2417. doi:10.1016/j.foodres.2010.12.038
Tang L-Q, Wei W, Chen L-M, Liu S (2006) Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108:109–115. doi:10.1016/j.jep.2006.04.019
Zhang Q et al (2011) Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol 49:61–69. doi:10.1016/j.fct.2010.09.032
Kalalian-Moghaddam H, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur J Pharmacol 698:259–266. doi:10.1016/j.ejphar.2012.10.020
Jahanshahi M, Golalipour MJ, Afshar M (2009) The effect of Urtica dioica extract on the number of astrocytes in the dentate gyrus of diabetic rats. Folia Morphol (Warsz) 68:93–97
Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95–111. doi:10.1016/S0074-7742(07)82005-8
O’Callaghan JP, Sriram K (2005) Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 4:433–442. doi:10.1517/14740338.4.3.433
Fernandez-Fernandez S, Almeida A, Bolanos JP (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem J 443:3–11. doi:10.1042/BJ20111943
Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem / FEBS 267:4912–4916
Yoo HJ et al (2008) Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract. J Ethnopharmacol 120:282–286. doi:10.1016/j.jep.2008.08.016
Ingkaninan K, Phengpa P, Yuenyongsawad S, Khorana N (2006) Acetylcholinesterase inhibitors from Stephania venosa tuber. J Pharm Pharmacol 58:695–700. doi:10.1211/jpp.58.5.0015
Dhir A, Naidu PS, Kulkarni SK (2007) Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure-Eur J Epilep 16:691–697. doi:10.1016/j.seizure.2007.05.016
Lu DY, Tang CH, Chen YH, Wei IH (2010) Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J Cell Biochem 110:697–705. doi:10.1002/jcb.22580
Liu Q, Chen L, Hu L, Guo Y, Shen X (2010) Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta 1799:854–865. doi:10.1016/j.bbagrm.2010.06.004
Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21:2–21
Acknowledgments
The authors would like to thank Ms. Zahra Amanpour and Dr. Aziz Ronaghi for their kind support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moghaddam, H.K., Baluchnejadmojarad, T., Roghani, M. et al. Berberine Ameliorate Oxidative Stress and Astrogliosis in the Hippocampus of STZ-Induced Diabetic Rats. Mol Neurobiol 49, 820–826 (2014). https://doi.org/10.1007/s12035-013-8559-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-013-8559-7